Branka Horvat Selected Research

Branka Horvat Research Topics

Disease

31	Infections 01/2024 - 07/2006
11	Measles 10/2022 - 11/2004
7	COVID-19 05/2023 - 07/2020
7	Henipavirus Infections 11/2020 - 01/2012
4	Virus Diseases (Viral Diseases) 12/2021 - 03/2015
3	Bites and Stings (Sting) 01/2023 - 06/2021
3	Paramyxoviridae Infections (Parainfluenza) 12/2021 - 01/2012
3	Multiple Sclerosis 10/2021 - 04/2017
3	Central Nervous System Infections (Central Nervous System Infection) 01/2021 - 11/2017
3	Subacute Sclerosing Panencephalitis (SSPE) 01/2021 - 01/2019
3	Encephalitis (Encephalitis, Rasmussen) 11/2019 - 01/2012
2	Neoplasms (Cancer) 06/2021 - 01/2015
2	Hypersensitivity (Allergy) 01/2009 - 01/2006
1	Inflammation (Inflammations) 11/2021
1	Disease Progression 04/2021
1	Ebola Hemorrhagic Fever 01/2020
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2017
1	Vesicular Stomatitis 01/2016
1	Glioma (Gliomas) 01/2015
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2012
1	Communicable Diseases (Infectious Diseases) 05/2009
1	Atherosclerosis 10/2007
1	Stroke (Strokes) 10/2007
1	Heart Diseases (Heart Disease) 10/2007
1	Atherosclerotic Plaque (Atheroma) 10/2007
1	Asymptomatic Infections 07/2006
1	Opportunistic Infections (Opportunistic Infection) 01/2006

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2006
13	Antiviral Agents (Antivirals)IBA 12/2021 - 01/2012
6	Peptides (Polypeptides)IBA 10/2022 - 12/2013
6	VaccinesIBA 12/2021 - 01/2006
5	InterferonsIBA 12/2021 - 01/2012
5	AntibodiesIBA 01/2021 - 07/2006
4	LipopeptidesIBA 01/2024 - 01/2018
4	Interferon Type IIBA 06/2021 - 01/2013
3	AerosolsIBA 01/2024 - 06/2022
3	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 05/2014
3	RNA (Ribonucleic Acid)IBA 10/2022 - 06/2021
3	CytokinesIBA 04/2021 - 10/2012
3	Immunoglobulin M (IgM)IBA 01/2021 - 05/2010
3	Glycoproteins (Glycoprotein)IBA 01/2021 - 01/2016
3	ChemokinesIBA 05/2014 - 01/2012
2	syncytinIBA 05/2023 - 10/2021
2	Viral RNAIBA 01/2023 - 03/2010
2	Viral DNAIBA 11/2022 - 05/2014
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2021
2	Peptide Hydrolases (Proteases)FDA Link 12/2021 - 01/2017
2	Immunoglobulin A (IgA)IBA 01/2021 - 07/2020
2	Immunoglobulin G (IgG)IBA 01/2021 - 07/2020
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 01/2019
2	Amino Acids FDA Link 01/2021 - 01/2019
2	Virus ReceptorsIBA 03/2015 - 01/2013
2	human CD46 proteinIBA 05/2014 - 01/2009
2	CholesterolIBA 12/2013 - 01/2012
2	Interleukin-12 (IL 12)IBA 01/2006 - 11/2004
1	Firefly LuciferasesIBA 12/2021
1	env Gene ProductsIBA 04/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 04/2021
1	SARS-CoV-2 spike proteinIBA 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Congo RedIBA 01/2021
1	Single-Chain AntibodiesIBA 01/2021
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2020
1	QuercetinIBA 01/2020
1	Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA 01/2019
1	17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA 11/2017
1	Measles VaccineIBA 05/2017
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2016
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2016
1	PhosphoproteinsIBA 01/2016
1	Heparitin Sulfate (Heparan Sulfate)IBA 03/2015
1	Heparin (Liquaemin)FDA LinkGeneric 03/2015
1	Ephrin-B3 (Ephrin B3)IBA 03/2015
1	Protein Isoforms (Isoforms)IBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	Toll-Like Receptor 9IBA 05/2014
1	Chemokine CCL5IBA 05/2014
1	Neutralizing AntibodiesIBA 01/2013
1	AntigensIBA 03/2010
1	Monoclonal AntibodiesIBA 05/2009
1	Interferon Receptors (Interferon Receptor)IBA 01/2009
1	Measles virus nucleoproteinIBA 10/2007
1	Interferon-alpha (Interferon Alfa)IBA 01/2006
1	NucleoproteinsIBA 11/2004

Therapy/Procedure

2	Therapeutics 11/2019 - 02/2015
1	Intravenous Injections 03/2010